is hers going to stop selling semaglutide Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Novo Nordisk halts Wegovy sales

Under IRS Publication 502 and Section 213 of the tax code, a medical expense is deductible only when it's used for the "diagnosis, cure, mitigation, treatment, or prevention of disease." In 2024, the IRS issued guidance (FS-2024-07) reaffirming this framework for GLP-1 medications specifically

clot concerns It would be irresponsible to discuss semaglutide blood clot risk without placing it in the context of the medication overall cardiovascular impact

Many women report significant reduction in joint discomfort and chronic pain

As of January 5, 2026, there are now 3,063 pending lawsuits in the general GLP-1 MDL and 29 pending lawsuits the NAION MDL

It is not a drug, supplement, cosmetic, food, or medical device, and it is not for human or veterinary use of any kind

What are GLP-1 agonist medications